Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Casgevy 4-13 x 10Exp6 cells/mL dispersion for infusion {equilateral_black_triangle}

Active Ingredient:
exagamglogene autotemcel
Company:  
Vertex Pharmaceuticals (Europe) Limited See contact details
ATC code: 
B06AX05
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

CASGEVY Guide for Patients and Carers

Important information about CASGEVY for patients and carers
{pdf_link}

CASGEVY Handling and Administration Guide

{healthcare_pro_orange} For Healthcare Professionals
Important information for Healthcare Professionals about CASGEVY
{pdf_link}

CASGEVY Patient Alert Card

Important information for patients regarding CASGEVY

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Vertex Pharmaceuticals (Europe) Limited
Company image
Address
2 Kingdom Street, London, W2 6BD, UK
Telephone
+44 (0)20 3204 5100
Medical Information Direct Line
0800 028 2616
Medical Information e-mail
[email protected]
Customer Care direct line
0800 028 2616